Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
2010
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
2017
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
2015
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
The Basic Principles of Chimeric Antigen Receptor Design
2013
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
A facile approach to enhance antigen response for personalized cancer vaccination
2018
Is autoimmunity the Achilles' heel of cancer immunotherapy?
2017
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
2017
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
2013
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Genetic engineering of T cells for immunotherapy
2021
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The Principles of Engineering Immune Cells to Treat Cancer
2017
Nasopharyngeal carcinoma
2019 Standout
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
2015
Adoptive immunotherapy for cancer: harnessing the T cell response
2012
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Designer vaccine nanodiscs for personalized cancer immunotherapy
2016
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Drug development in the era of precision medicine
2017
Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
2016
Emerging Biological Principles of Metastasis
2017 Standout
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
2016
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
2011
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Engineered T cells for cancer therapy
2014
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
2017
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
2010
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 Nature
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells
2015
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
2018
mRNA Cancer Vaccines
2016
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Adoptive Immunotherapy for Cancer or Viruses
2014
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
2013
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Adoptive cellular therapy: A race to the finish line
2015
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Chimeric Antigen Receptor Therapy
2018 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Neoantigen landscape dynamics during human melanoma–T cell interactions
2016 Nature
Neoantigens in cancer immunotherapy
2015 StandoutScience
Therapeutic cancer vaccines
2015
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
2021
Works of Laura Bies being referenced
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
2010
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
2014
Blockade of TGF-β Signaling Greatly Enhances the Efficacy of TCR Gene Therapy of Cancer
2013